Metabolites: deciphering the molecular language between DCs and their environment

1.

Mayer CT, Berod L, Sparwasser T (2012) Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity. Front Immunol 3:183. doi:10.3389/fimmu.2012.00183 PubMedPubMedCentralCrossRef

2.

Kim JM, Rasmussen JP, Rudensky AY (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8(2):191–197. doi:10.1038/ni1428 PubMedCrossRef

3.

Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, Sparwasser T (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204(1):57–63. doi:10.1084/jem.20061852 PubMedPubMedCentralCrossRef

4.

Sakaguchi S (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531–562. doi:10.1146/annurev.immunol.21.120601.141122 PubMedCrossRef

5.

Swee LK, Bosco N, Malissen B, Ceredig R, Rolink A (2009) Expansion of peripheral naturally occurring T regulatory cells by fms-like tyrosine kinase 3 ligand treatment. Blood 113(25):6277–6287. doi:10.1182/blood-2008-06-161026 PubMedCrossRef

6.

Collins CB, Aherne CM, McNamee EN, Lebsack MD, Eltzschig H, Jedlicka P, Rivera-Nieves J (2012) Flt3 ligand expands CD103(+) dendritic cells and FoxP3 (+) T regulatory cells, and attenuates Crohn's-like murine ileitis. Gut 61(8):1154–1162. doi:10.1136/gutjnl-2011-300820 PubMedCrossRef

7.

Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204(8):1757–1764. doi:10.1084/jem.20070590 PubMedPubMedCentralCrossRef

8.

Yamazaki S, Dudziak D, Heidkamp GF, Fiorese C, Bonito AJ, Inaba K, Nussenzweig MC, Steinman RM (2008) CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J Immunol 181(10):6923–6933PubMedPubMedCentralCrossRef

9.

Darrasse-Jeze G, Deroubaix S, Mouquet H, Victora GD, Eisenreich T, Yao KH, Masilamani RF, Dustin ML, Rudensky A, Liu K, Nussenzweig MC (2009) Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 206(9):1853–1862. doi:10.1084/jem.20090746 PubMedPubMedCentralCrossRef

10.

Ohnmacht C, Pullner A, King SB, Drexler I, Meier S, Brocker T, Voehringer D (2009) Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 206(3):549–559. doi:10.1084/jem.20082394 PubMedPubMedCentralCrossRef

11.

Collin M, Bigley V, Haniffa M, Hambleton S (2011) Human dendritic cell deficiency: the missing ID? Nat Rev Immunol 11(9):575–583. doi:10.1038/nri3046 PubMedCrossRef

12.

Bigley V, Haniffa M, Doulatov S, Wang XN, Dickinson R, McGovern N, Jardine L, Pagan S, Dimmick I, Chua I, Wallis J, Lordan J, Morgan C, Kumararatne DS, Doffinger R, van der Burg M, van Dongen J, Cant A, Dick JE, Hambleton S, Collin M (2011) The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 208(2):227–234. doi:10.1084/jem.20101459 PubMedPubMedCentralCrossRef

13.

Esterhazy D, Loschko J, London M, Jove V, Oliveira TY, Mucida D (2016) Classical dendritic cells are required for dietary antigen-mediated induction of peripheral Treg cells and tolerance. Nat Immunol 17(5):545–555. doi:10.1038/ni.3408 PubMedPubMedCentralCrossRef

14.

Amodio G, Gregori S (2012) Dendritic cells a double-edge sword in autoimmune responses. Front Immunol 3:233. doi:10.3389/fimmu.2012.00233 PubMedPubMedCentralCrossRef

15.

Pearce EJ, Everts B (2015) Dendritic cell metabolism. Nat Rev Immunol 15(1):18–29. doi:10.1038/nri3771 PubMedPubMedCentralCrossRef

16.

Luckey TD (1972) Introduction to intestinal microecology. Am J Clin Nutr 25(12):1292–1294PubMed

17.

Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, Marsland BJ (2014) Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20(2):159–166. doi:10.1038/nm.3444 PubMedCrossRef

18.

Graf D, Di Cagno R, Fak F, Flint HJ, Nyman M, Saarela M, Watzl B (2015) Contribution of diet to the composition of the human gut microbiota. Microb Ecol Health Dis 26:26164. doi:10.3402/mehd.v26.26164 PubMed

19.

Manzel A, Muller DN, Hafler DA, Erdman SE, Linker RA, Kleinewietfeld M (2014) Role of "western diet" in inflammatory autoimmune diseases. Current allergy and asthma reports 14(1):404. doi:10.1007/s11882-013-0404-6 PubMedPubMedCentralCrossRef

20.

Leslie RD, Hawa M (1994) Twin studies in auto-immune disease. Acta Genet Med Gemellol 43(1–2):71–81PubMedCrossRef

21.

Strachan DP (1989) Hay fever, hygiene, and household size. BMJ 299(6710):1259–1260PubMedPubMedCentralCrossRef

22.

Walk ST, Blum AM, Ewing SA, Weinstock JV, Young VB (2010) Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis 16(11):1841–1849. doi:10.1002/ibd.21299 PubMedPubMedCentralCrossRef

23.

Rausch S, Held J, Fischer A, Heimesaat MM, Kuhl AA, Bereswill S, Hartmann S (2013) Small intestinal nematode infection of mice is associated with increased enterobacterial loads alongside the intestinal tract. PLoS One 8(9):e74026. doi:10.1371/journal.pone.0074026 PubMedPubMedCentralCrossRef

24.

Reynolds LA, Smith KA, Filbey KJ, Harcus Y, Hewitson JP, Redpath SA, Valdez Y, Yebra MJ, Finlay BB, Maizels RM (2014) Commensal-pathogen interactions in the intestinal tract: lactobacilli promote infection with, and are promoted by, helminth parasites. Gut Microbes 5(4):522–532. doi:10.4161/gmic.32155 PubMedPubMedCentralCrossRef

25.

Holm JB, Sorobetea D, Kiilerich P, Ramayo-Caldas Y, Estelle J, Ma T, Madsen L, Kristiansen K, Svensson-Frej M (2015) Chronic Trichuris muris infection decreases diversity of the intestinal microbiota and concomitantly increases the abundance of lactobacilli. PLoS One 10(5):e0125495. doi:10.1371/journal.pone.0125495 PubMedPubMedCentralCrossRef

26.

Houlden A, Hayes KS, Bancroft AJ, Worthington JJ, Wang P, Grencis RK, Roberts IS (2015) Chronic Trichuris muris infection in C57BL/6 mice causes significant changes in host microbiota and metabolome: effects reversed by pathogen clearance. PLoS One 10(5):e0125945. doi:10.1371/journal.pone.0125945 PubMedPubMedCentralCrossRef

27.

Kay GL, Millard A, Sergeant MJ, Midzi N, Gwisai R, Mduluza T, Ivens A, Nausch N, Mutapi F, Pallen M (2015) Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children. PLoS neglected tropical diseases 9(6):e0003861. doi:10.1371/journal.pntd.0003861 PubMedPubMedCentralCrossRef

28.

Lee SC, Tang MS, Lim YA, Choy SH, Kurtz ZD, Cox LM, Gundra UM, Cho I, Bonneau R, Blaser MJ, Chua KH, Loke P (2014) Helminth colonization is associated with increased diversity of the gut microbiota. PLoS Negl Trop Dis 8(5):e2880. doi:10.1371/journal.pntd.0002880 PubMedPubMedCentralCrossRef

29.

Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM (1990) The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med 171(5):1753–1771PubMedCrossRef

30.

Homann D, Jahreis A, Wolfe T, Hughes A, Coon B, van Stipdonk MJ, Prilliman KR, Schoenberger SP, von Herrath MG (2002) CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16(3):403–415PubMedCrossRef

31.

Lin Y, Roberts TJ, Sriram V, Cho S, Brutkiewicz RR (2003) Myeloid marker expression on antiviral CD8+ T cells following an acute virus infection. Eur J Immunol 33(10):2736–2743. doi:10.1002/eji.200324087 PubMedCrossRef

32.

Huleatt JW, Lefrancois L (1995) Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. J Immunol 154(11):5684–5693PubMed

33.

Heng TS, Painter MW, Immunological Genome Project C (2008) The immunological genome project: networks of gene expression in immune cells. Nat Immunol 9(10):1091–1094. doi:10.1038/ni1008-1091 CrossRef

34.

Arnold-Schrauf C, Berod L, Sparwasser T (2015) Dendritic cell specific targeting of MyD88 signalling pathways in vivo. Eur J Immunol 45(1):32–39. doi:10.1002/eji.201444747 PubMedCrossRef

35.

Dudek M, Puttur F, Arnold-Schrauf C, Kuhl AA, Holzmann B, Henriques-Normark B, Berod L, Sparwasser T (2015) Lung epithelium and myeloid cells cooperate to clear acute pneumococcal infection. Mucosal immunology. doi:10.1038/mi.2015.128 PubMedPubMedCentral

36.

Satpathy AT, Kc W, Albring JC, Edelson BT, Kretzer NM, Bhattacharya D, Murphy TL, Murphy KM (2012) Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med 209(6):1135–1152. doi:10.1084/jem.20120030 PubMedPubMedCentralCrossRef

37.

Meredith MM, Liu K, Darrasse-Jeze G, Kamphorst AO, Schreiber HA, Guermonprez P, Idoyaga J, Cheong C, Yao KH, Niec RE, Nussenzweig MC (2012) Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J Exp Med 209(6):1153–1165. doi:10.1084/jem.20112675 PubMedPubMedCentralCrossRef

38.

Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU, Segura E, Tussiwand R, Yona S (2014) Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol 14(8):571–578. doi:10.1038/nri3712 PubMedPubMedCentralCrossRef

39.

Martin-Fontecha A, Lanzavecchia A, Sallusto F (2009) Dendritic cell migration to peripheral lymph nodes. Handb Exp Pharmacol 188:31–49. doi:10.1007/978-3-540-71029-5_2 CrossRef

40.

Bachem A, Guttler S, Hartung E, Ebstein F, Schaefer M, Tannert A, Salama A, Movassaghi K, Opitz C, Mages HW, Henn V, Kloetzel PM, Gurka S, Kroczek RA (2010) Superior antigen cross-presentation and XCR1 expression define human CD11c + CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med 207(6):1273–1281. doi:10.1084/jem.20100348 PubMedPubMedCentralCrossRef

41.

Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, Wasan PS, Wang XN, Malinarich F, Malleret B, Larbi A, Tan P, Zhao H, Poidinger M, Pagan S, Cookson S, Dickinson R, Dimmick I, Jarrett RF, Renia L, Tam J, Song C, Connolly J, Chan JK, Gehring A, Bertoletti A, Collin M, Ginhoux F (2012) Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 37(1):60–73. doi:10.1016/j.immuni.2012.04.012 PubMedPubMedCentralCrossRef

42.

Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, Chen CJ, Dunbar PR, Wadley RB, Jeet V, Vulink AJ, Hart DN, Radford KJ (2010) Human CD141+ (BDCA-3) + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 207(6):1247–1260. doi:10.1084/jem.20092140 PubMedPubMedCentralCrossRef

43.

Yu CI, Becker C, Wang Y, Marches F, Helft J, Leboeuf M, Anguiano E, Pourpe S, Goller K, Pascual V, Banchereau J, Merad M, Palucka K (2013) Human CD1c + dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-beta. Immunity 38(4):818–830. doi:10.1016/j.immuni.2013.03.004 PubMedPubMedCentralCrossRef

44.

Crozat K, Guiton R, Contreras V, Feuillet V, Dutertre CA, Ventre E, Vu Manh TP, Baranek T, Storset AK, Marvel J, Boudinot P, Hosmalin A, Schwartz-Cornil I, Dalod M (2010) The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha + dendritic cells. J Exp Med 207(6):1283–1292. doi:10.1084/jem.20100223 PubMedPubMedCentralCrossRef

45.

Poulin LF, Salio M, Griessinger E, Anjos-Afonso F, Craciun L, Chen JL, Keller AM, Joffre O, Zelenay S, Nye E, Le Moine A, Faure F, Donckier V, Sancho D, Cerundolo V, Bonnet D, Reis-e Sousa C (2010) Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha + dendritic cells. J Exp Med 207(6):1261–1271. doi:10.1084/jem.20092618 PubMedPubMedCentralCrossRef

46.

den Haan JM, Lehar SM, Bevan MJ (2000) CD8(+) but not CD8(−) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192(12):1685–1696CrossRef

47.

Pooley JL, Heath WR, Shortman K (2001) Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol 166(9):5327–5330PubMedCrossRef

48.

Iyoda T, Shimoyama S, Liu K, Omatsu Y, Akiyama Y, Maeda Y, Takahara K, Steinman RM, Inaba K (2002) The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 195(10):1289–1302PubMedPubMedCentralCrossRef

49.

Schulz O, Reis e Sousa C (2002) Cross-presentation of cell-associated antigens by CD8alpha + dendritic cells is attributable to their ability to internalize dead cells. Immunology 107(2):183–189PubMedPubMedCentralCrossRef

50.

Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, Calderon B, Schraml BU, Unanue ER, Diamond MS, Schreiber RD, Murphy TL, Murphy KM (2008) Batf3 deficiency reveals a critical role for CD8alpha + dendritic cells in cytotoxic T cell immunity. Science 322(5904):1097–1100. doi:10.1126/science.1164206 PubMedPubMedCentralCrossRef

51.

Belz GT, Smith CM, Eichner D, Shortman K, Karupiah G, Carbone FR, Heath WR (2004) Cutting edge: conventional CD8 alpha + dendritic cells are generally involved in priming CTL immunity to viruses. J Immunol 172(4):1996–2000PubMedCrossRef

52.

Mashayekhi M, Sandau MM, Dunay IR, Frickel EM, Khan A, Goldszmid RS, Sher A, Ploegh HL, Murphy TL, Sibley LD, Murphy KM (2011) CD8alpha(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by toxoplasma gondii tachyzoites. Immunity 35(2):249–259. doi:10.1016/j.immuni.2011.08.008 PubMedPubMedCentralCrossRef

53.

Hopp AK, Rupp A, Lukacs-Kornek V (2014) Self-antigen presentation by dendritic cells in autoimmunity. Front Immunol 5:55. doi:10.3389/fimmu.2014.00055 PubMedPubMedCentralCrossRef

54.

Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P, O'Keeffe M (2001) Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol 166(9):5448–5455PubMedCrossRef

55.

Edelson BT, Kc W, Juang R, Kohyama M, Benoit LA, Klekotka PA, Moon C, Albring JC, Ise W, Michael DG, Bhattacharya D, Stappenbeck TS, Holtzman MJ, Sung SS, Murphy TL, Hildner K, Murphy KM (2010) Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha + conventional dendritic cells. J Exp Med 207(4):823–836. doi:10.1084/jem.20091627 PubMedPubMedCentralCrossRef

56.

Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, Ho AW, See P, Shin A, Wasan PS, Hoeffel G, Malleret B, Heiseke A, Chew S, Jardine L, Purvis HA, Hilkens CM, Tam J, Poidinger M, Stanley ER, Krug AB, Renia L, Sivasankar B, Ng LG, Collin M, Ricciardi-Castagnoli P, Honda K, Haniffa M, Ginhoux F (2013) IRF4 transcription factor-dependent CD11b + dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38(5):970–983. doi:10.1016/j.immuni.2013.04.011 PubMedPubMedCentralCrossRef

57.

Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S, Cheong C, Liu K, Lee HW, Park CG, Steinman RM, Nussenzweig MC (2007) Differential antigen processing by dendritic cell subsets in vivo. Science 315(5808):107–111. doi:10.1126/science.1136080 PubMedCrossRef

58.

Lewis KL, Caton ML, Bogunovic M, Greter M, Grajkowska LT, Ng D, Klinakis A, Charo IF, Jung S, Gommerman JL, Ivanov II, Liu K, Merad M, Reizis B (2011) Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine. Immunity 35(5):780–791. doi:10.1016/j.immuni.2011.08.013 PubMedPubMedCentralCrossRef

59.

Tamoutounour S, Henri S, Lelouard H, de Bovis B, de Haar C, van der Woude CJ, Woltman AM, Reyal Y, Bonnet D, Sichien D, Bain CC, Mowat AM, Reis e Sousa C, Poulin LF, Malissen B, Guilliams M (2012) CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur J Immunol 42(12):3150–3166. doi:10.1002/eji.201242847 PubMedCrossRef

60.

Plantinga M, Guilliams M, Vanheerswynghels M, Deswarte K, Branco-Madeira F, Toussaint W, Vanhoutte L, Neyt K, Killeen N, Malissen B, Hammad H, Lambrecht BN (2013) Conventional and monocyte-derived CD11b (+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 38(2):322–335. doi:10.1016/j.immuni.2012.10.016 PubMedCrossRef

61.

Idoyaga J, Fiorese C, Zbytnuik L, Lubkin A, Miller J, Malissen B, Mucida D, Merad M, Steinman RM Specialized role of migratory dendritic cells in peripheral tolerance induction. J Clin Invest 123(2):844–854. doi:10.1172/JCI65260

62.

Kim TS, Gorski SA, Hahn S, Murphy KM, Braciale TJ (2014) Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8 (+) T cell differentiation by a CD24-dependent mechanism. Immunity 40(3):400–413. doi:10.1016/j.immuni.2014.02.004 PubMedPubMedCentralCrossRef

63.

Cerovic V, Bain CC, Mowat AM, Milling SW (2014) Intestinal macrophages and dendritic cells: what's the difference? Trends Immunol 35(6):270–277. doi:10.1016/j.it.2014.04.003 PubMedCrossRef

64.

Merad M, Sathe P, Helft J, Miller J, Mortha A (2013) The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31:563–604. doi:10.1146/annurev-immunol-020711-074950 PubMedCrossRef

65.

Tamoutounour S, Guilliams M, Montanana Sanchis F, Liu H, Terhorst D, Malosse C, Pollet E, Ardouin L, Luche H, Sanchez C, Dalod M, Malissen B, Henri S (2013) Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 39(5):925–938. doi:10.1016/j.immuni.2013.10.004 PubMedCrossRef

66.

Chorro L, Sarde A, Li M, Woollard KJ, Chambon P, Malissen B, Kissenpfennig A, Barbaroux JB, Groves R, Geissmann F (2009) Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med 206(13):3089–3100. doi:10.1084/jem.20091586 PubMedPubMedCentralCrossRef

67.

Hoeffel G, Wang Y, Greter M, See P, Teo P, Malleret B, Leboeuf M, Low D, Oller G, Almeida F, Choy SH, Grisotto M, Renia L, Conway SJ, Stanley ER, Chan JK, Ng LG, Samokhvalov IM, Merad M, Ginhoux F (2012) Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med 209(6):1167–1181. doi:10.1084/jem.20120340 PubMedPubMedCentralCrossRef

68.

Malissen B, Tamoutounour S, Henri S (2014) The origins and functions of dendritic cells and macrophages in the skin. Nat Rev Immunol 14(6):417–428. doi:10.1038/nri3683 PubMedCrossRef

69.

Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176(6):1693–1702PubMedCrossRef

70.

Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223(1):77–92PubMedCrossRef

71.

Helft J, Bottcher J, Chakravarty P, Zelenay S, Huotari J, Schraml BU, Goubau D, Reis e Sousa C (2015) GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c (+) MHCII (+) macrophages and dendritic cells. Immunity 42(6):1197–1211. doi:10.1016/j.immuni.2015.05.018 PubMedCrossRef

72.

Naik SH, Metcalf D, van Nieuwenhuijze A, Wicks I, Wu L, O'Keeffe M, Shortman K (2006) Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol 7(6):663–671. doi:10.1038/ni1340 PubMedCrossRef

73.

Mayer CT, Ghorbani P, Nandan A, Dudek M, Arnold-Schrauf C, Hesse C, Berod L, Stuve P, Puttur F, Merad M, Sparwasser T (2014) Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow. Blood 124(20):3081–3091. doi:10.1182/blood-2013-12-545772 PubMedPubMedCentralCrossRef

74.

Proietto AI, Mittag D, Roberts AW, Sprigg N, Wu L (2012) The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34 (+) stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin. Cellular & molecular immunology 9(6):446–454. doi:10.1038/cmi.2012.48 CrossRef

75.

Pantel A, Teixeira A, Haddad E, Wood EG, Steinman RM, Longhi MP (2014) Direct type I IFN but not MDA5/TLR3 activation of dendritic cells is required for maturation and metabolic shift to glycolysis after poly IC stimulation. PLoS Biol 12(1):e1001759. doi:10.1371/journal.pbio.1001759 PubMedPubMedCentralCrossRef

76.

Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ, Cross JR, Jung E, Thompson CB, Jones RG, Pearce EJ (2010) Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115(23):4742–4749. doi:10.1182/blood-2009-10-249540 PubMedPubMedCentralCrossRef

77.

Everts B, Amiel E, Huang SC, Smith AM, Chang CH, Lam WY, Redmann V, Freitas TC, Blagih J, van der Windt GJ, Artyomov MN, Jones RG, Pearce EL, Pearce EJ (2014) TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation. Nat Immunol 15(4):323–332. doi:10.1038/ni.2833 PubMedPubMedCentralCrossRef

78.

Everts B, Amiel E, van der Windt GJ, Freitas TC, Chott R, Yarasheski KE, Pearce EL, Pearce EJ (2012) Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood 120(7):1422–1431. doi:10.1182/blood-2012-03-419747 PubMedPubMedCentralCrossRef

79.

Jantsch J, Chakravortty D, Turza N, Prechtel AT, Buchholz B, Gerlach RG, Volke M, Glasner J, Warnecke C, Wiesener MS, Eckardt KU, Steinkasserer A, Hensel M, Willam C (2008) Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J Immunol 180(7):4697–4705PubMedCrossRef

80.

Bhandari T, Olson J, Johnson RS, Nizet V (2013) HIF-1alpha influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination. J Mol Med 91(10):1199–1205. doi:10.1007/s00109-013-1052-y PubMedPubMedCentralCrossRef

81.

Berod L, Sparwasser T (2016) pDCs take a deep breath to fight viruses. Immunity 44(6):1246–1248. doi:10.1016/j.immuni.2016.06.005 PubMedCrossRef

82.

Wu D, Sanin DE, Everts B, Chen Q, Qiu J, Buck MD, Patterson A, Smith AM, Chang CH, Liu Z, Artyomov MN, Pearce EL, Cella M, Pearce EJ (2016) Type 1 interferons induce changes in Core metabolism that are critical for immune function. Immunity 44(6):1325–1336. doi:10.1016/j.immuni.2016.06.006 PubMedCrossRef

83.

O'Neill LA, Pearce EJ (2016) Immunometabolism governs dendritic cell and macrophage function. J Exp Med 213(1):15–23. doi:10.1084/jem.20151570 PubMedPubMedCentralCrossRef

84.

Rubic T, Lametschwandtner G, Jost S, Hinteregger S, Kund J, Carballido-Perrig N, Schwarzler C, Junt T, Voshol H, Meingassner JG, Mao X, Werner G, Rot A, Carballido JM (2008) Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol 9(11):1261–1269. doi:10.1038/ni.1657 PubMedCrossRef

85.

Wani R, Nagata A, Murray BW (2014) Protein redox chemistry: post-translational cysteine modifications that regulate signal transduction and drug pharmacology. Front Pharmacol 5:224. doi:10.3389/fphar.2014.00224 PubMedPubMedCentralCrossRef

86.

Rooks MG, Garrett WS (2016) Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16(6):341–352. doi:10.1038/nri.2016.42 PubMedCrossRef

87.

Passalacqua KD, Charbonneau ME, O'Riordan MX (2016) Bacterial metabolism shapes the host-pathogen Interface. Microbiology spectrum 4(3). doi:10.1128/microbiolspec.VMBF-0027-2015

88.

Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N, Ravichandran KS (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461(7261):282–286. doi:10.1038/nature08296 PubMedPubMedCentralCrossRef

89.

Homolya L, Steinberg TH, Boucher RC (2000) Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia. J Cell Biol 150(6):1349–1360PubMedPubMedCentralCrossRef

90.

Pakdeechote P, Rummery NM, Ralevic V, Dunn WR (2007) Raised tone reveals purinergic-mediated responses to sympathetic nerve stimulation in the rat perfused mesenteric vascular bed. Eur J Pharmacol 563(1–3):180–186. doi:10.1016/j.ejphar.2007.02.011 PubMedCrossRef

91.

Deaglio S, Robson SC (2011) Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol 61:301–332. doi:10.1016/B978-0-12-385526-8.00010-2 PubMedCrossRef

92.

Fredholm BB, Irenius E, Kull B, Schulte G (2001) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61(4):443–448PubMedCrossRef

93.

Cabrita MA, Baldwin SA, Young JD, Cass CE (2002) Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes. Biochemistry and cell biology = Biochimie et biologie cellulaire 80(5):623–638PubMedCrossRef

94.

Pastor-Anglada M, Casado FJ, Valdes R, Mata J, Garcia-Manteiga J, Molina M (2001) Complex regulation of nucleoside transporter expression in epithelial and immune system cells. Mol Membr Biol 18(1):81–85PubMedCrossRef

95.

Burnstock G, Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16(5):433–440PubMedCrossRef

96.

Panther E, Idzko M, Herouy Y, Rheinen H, Gebicke-Haerter PJ, Mrowietz U, Dichmann S, Norgauer J (2001) Expression and function of adenosine receptors in human dendritic cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 15(11):1963–1970. doi:10.1096/fj.01-0169com CrossRef

97.

Panther E, Corinti S, Idzko M, Herouy Y, Napp M, la Sala A, Girolomoni G, Norgauer J (2003) Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 101(10):3985–3990. doi:10.1182/blood-2002-07-2113 PubMedCrossRef

98.

Challier J, Bruniquel D, Sewell AK, Laugel B (2013) Adenosine and cAMP signalling skew human dendritic cell differentiation towards a tolerogenic phenotype with defective CD8 (+) T-cell priming capacity. Immunology 138(4):402–410. doi:10.1111/imm.12053 PubMedPubMedCentralCrossRef

99.

Ben Addi A, Lefort A, Hua X, Libert F, Communi D, Ledent C, Macours P, Tilley SL, Boeynaems JM, Robaye B (2008) Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the a(2B) receptor. Eur J Immunol 38(6):1610–1620. doi:10.1002/eji.200737781 PubMedCrossRef

100.

Wilson JM, Ross WG, Agbai ON, Frazier R, Figler RA, Rieger J, Linden J, Ernst PB (2009) The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells. J Immunol 182(8):4616–4623. doi:10.4049/jimmunol.0801279 PubMedPubMedCentralCrossRef

101.

Ring S, Pushkarevskaya A, Schild H, Probst HC, Jendrossek V, Wirsdorfer F, Ledent C, Robson SC, Enk AH, Mahnke K (2015) Regulatory T cell-derived adenosine induces dendritic cell migration through the Epac-Rap1 pathway. J Immunol 194(8):3735–3744. doi:10.4049/jimmunol.1401434 PubMedCrossRef

102.

Takenaka MC, Robson S, Quintana FJ (2016) Regulation of the T cell response by CD39. Trends Immunol 37(7):427–439. doi:10.1016/j.it.2016.04.009 PubMedCrossRef

103.

Molle C, Goldman M, Goriely S (2010) Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process. J Immunol 184(4):1784–1792. doi:10.4049/jimmunol.0902005 PubMedCrossRef

104.

Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner HL (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8(12):1380–1389. doi:10.1038/ni1541 PubMedCrossRef

105.

Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7(9):929–936. doi:10.1038/ni1375 PubMedCrossRef

106.

Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, Saris CJ, Gran B, Ciric B, Rostami A (2007) Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8(12):1372–1379. doi:10.1038/ni1540 PubMedCrossRef

107.

Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, Villarino AV, Huang Q, Yoshimura A, Sehy D, Saris CJ, O'Shea JJ, Hennighausen L, Ernst M, Hunter CA (2006) Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7(9):937–945. doi:10.1038/ni1376 PubMedCrossRef

108.

Karakhanova S, Bedke T, Enk AH, Mahnke K (2011) IL-27 renders DC immunosuppressive by induction of B7-H1. J Leukoc Biol 89(6):837–845. doi:10.1189/jlb.1209788 PubMedCrossRef

109.

Wang S, Miyazaki Y, Shinozaki Y, Yoshida H (2007) Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1 (IL-27R) deficiency. J Immunol 179(10):6421–6428PubMedCrossRef

110.

Mascanfroni ID, Yeste A, Vieira SM, Burns EJ, Patel B, Sloma I, Wu Y, Mayo L, Ben-Hamo R, Efroni S, Kuchroo VK, Robson SC, Quintana FJ (2013) IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat Immunol 14(10):1054–1063. doi:10.1038/ni.2695 PubMedPubMedCentralCrossRef

111.

Ghaemi Oskouie F, Shameli A, Yang A, Desrosiers MD, Mucsi AD, Blackburn MR, Yang Y, Santamaria P, Shi Y (2011) High levels of adenosine deaminase on dendritic cells promote autoreactive T cell activation and diabetes in nonobese diabetic mice. J Immunol 186(12):6798–6806. doi:10.4049/jimmunol.1004222 PubMedCrossRef

112.

Pacheco R, Martinez-Navio JM, Lejeune M, Climent N, Oliva H, Gatell JM, Gallart T, Mallol J, Lluis C, Franco R (2005) CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci U S A 102(27):9583–9588. doi:10.1073/pnas.0501050102 PubMedPubMedCentralCrossRef

113.

Desrosiers MD, Cembrola KM, Fakir MJ, Stephens LA, Jama FM, Shameli A, Mehal WZ, Santamaria P, Shi Y (2007) Adenosine deamination sustains dendritic cell activation in inflammation. J Immunol 179(3):1884–1892PubMedCrossRef

114.

Casanova V, Naval-Macabuhay I, Massanella M, Rodriguez-Garcia M, Blanco J, Gatell JM, Garcia F, Gallart T, Lluis C, Mallol J, Franco R, Climent N, McCormick PJ (2012) Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals. PLoS One 7(12):e51287. doi:10.1371/journal.pone.0051287 PubMedPubMedCentralCrossRef

115.

Frick JS, MacManus CF, Scully M, Glover LE, Eltzschig HK, Colgan SP (2009) Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J Immunol 182(8):4957–4964. doi:10.4049/jimmunol.0801324 PubMedPubMedCentralCrossRef

116.

Friedman DJ, Kunzli BM, YI, AR, Sevigny J, Berberat PO, Enjyoji K, Csizmadia E, Friess H, Robson SC (2009) From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A 106 (39):16788–16793. doi:10.1073/pnas.0902869106

117.

Blay J, White TD, Hoskin DW (1997) The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res 57(13):2602–2605PubMed

118.

Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z (2011) Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol 187(2):676–683. doi:10.4049/jimmunol.1003884 PubMedCrossRef

119.

Novitskiy SV, Ryzhov S, Zaynagetdinov R, Goldstein AE, Huang Y, Tikhomirov OY, Blackburn MR, Biaggioni I, Carbone DP, Feoktistov I, Dikov MM (2008) Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 112(5):1822–1831. doi:10.1182/blood-2008-02-136325 PubMedPubMedCentralCrossRef

120.

Cekic C, Sag D, Li Y, Theodorescu D, Strieter RM, Linden J (2012) Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J Immunol 188(1):198–205. doi:10.4049/jimmunol.1101845 PubMedCrossRef

121.

Leone RD, Lo YC, Powell JD (2015) A2aR antagonists: next generation checkpoint blockade for cancer immunotherapy. Computational and structural biotechnology journal 13:265–272. doi:10.1016/j.csbj.2015.03.008 PubMedPubMedCentralCrossRef

122.

Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R, Guidotti G, Cantiello HF (1993) The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci U S A 90(1):312–316PubMedPubMedCentralCrossRef

123.

Chekeni FB, Elliott MR, Sandilos JK, Walk SF, Kinchen JM, Lazarowski ER, Armstrong AJ, Penuela S, Laird DW, Salvesen GS, Isakson BE, Bayliss DA, Ravichandran KS (2010) Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 467(7317):863–867. doi:10.1038/nature09413 PubMedPubMedCentralCrossRef

124.

Schwiebert EM, Egan ME, Hwang TH, Fulmer SB, Allen SS, Cutting GR, Guggino WB (1995) CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 81(7):1063–1073PubMedCrossRef

125.

Idzko M, Dichmann S, Ferrari D, Di Virgilio F, la Sala A, Girolomoni G, Panther E, Norgauer J (2002) Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 100(3):925–932PubMedCrossRef

126.

Liu QH, Bohlen H, Titzer S, Christensen O, Diehl V, Hescheler J, Fleischmann BK (1999) Expression and a role of functionally coupled P2Y receptors in human dendritic cells. FEBS Lett 445(2–3):402–408PubMedCrossRef

127.

Coutinho-Silva R, Persechini PM, Bisaggio RD, Perfettini JL, Neto AC, Kanellopoulos JM, Motta-Ly I, Dautry-Varsat A, Ojcius DM (1999) P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am J Phys 276(5 Pt 1):C1139–C1147

128.

Ferrari D, La Sala A, Chiozzi P, Morelli A, Falzoni S, Girolomoni G, Idzko M, Dichmann S, Norgauer J, Di Virgilio F (2000) The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 14(15):2466–2476. doi:10.1096/fj.00-0031com CrossRef

129.

Nihei OK, de Carvalho AC, Savino W, Alves LA (2000) Pharmacologic properties of P (2Z)/P2X (7 )receptor characterized in murine dendritic cells: role on the induction of apoptosis. Blood 96(3):996–1005PubMed

130.

Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, Griffiths RJ, Gabel CA (2001) Altered cytokine production in mice lacking P2X (7) receptors. J Biol Chem 276(1):125–132. doi:10.1074/jbc.M006781200 PubMedCrossRef

131.

Perregaux D, Gabel CA (1994) Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 269(21):15195–15203PubMed

132.

Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440(7081):228–232. doi:10.1038/nature04515 PubMedCrossRef

133.

Greenberg S, Di Virgilio F, Steinberg TH, Silverstein SC (1988) Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms. J Biol Chem 263(21):10337–10343PubMed

134.

Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini JL, Schlemmer F, Tasdemir E, Uhl M, Genin P, Civas A, Ryffel B, Kanellopoulos J, Tschopp J, Andre F, Lidereau R, McLaughlin NM, Haynes NM, Smyth MJ, Kroemer G, Zitvogel L (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15(10):1170–1178. doi:10.1038/nm.2028 PubMedCrossRef

135.

la Sala A, Ferrari D, Corinti S, Cavani A, Di Virgilio F, Girolomoni G (2001) Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J Immunol 166(3):1611–1617PubMedCrossRef

136.

Ivanova EP, Alexeeva YV, Pham DK, Wright JP, Nicolau DV (2006) ATP level variations in heterotrophic bacteria during attachment on hydrophilic and hydrophobic surfaces. International microbiology : the official journal of the Spanish Society for Microbiology 9(1):37–46

137.

Mempin R, Tran H, Chen C, Gong H, Kim Ho K, Lu S (2013) Release of extracellular ATP by bacteria during growth. BMC Microbiol 13:301. doi:10.1186/1471-2180-13-301 PubMedPubMedCentralCrossRef

138.

Hironaka I, Iwase T, Sugimoto S, Okuda K, Tajima A, Yanaga K, Mizunoe Y (2013) Glucose triggers ATP secretion from bacteria in a growth-phase-dependent manner. Appl Environ Microbiol 79(7):2328–2335. doi:10.1128/AEM.03871-12 PubMedPubMedCentralCrossRef

139.

Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, Onoue M, Yagita H, Ishii N, Evans R, Honda K, Takeda K (2008) ATP drives lamina propria T (H) 17 cell differentiation. Nature 455(7214):808–812. doi:10.1038/nature07240 PubMedCrossRef

140.

Neves AR, Castelo-Branco MT, Figliuolo VR, Bernardazzi C, Buongusto F, Yoshimoto A, Nanini HF, Coutinho CM, Carneiro AJ, Coutinho-Silva R, de Souza HS (2014) Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease. Inflamm Bowel Dis 20(3):444–457. doi:10.1097/01.MIB.0000441201.10454.06 PubMedCrossRef

141.

Castro CN, Freitag J, Berod L, Lochner M, Sparwasser T (2015) Microbe-associated immunomodulatory metabolites: Influence on T cell fate and function. Molecular immunology 68(2 Pt C):575–584. doi:10.1016/j.molimm.2015.07.025 PubMedCrossRef

142.

Macfarlane S, Macfarlane GT (2003) Regulation of short-chain fatty acid production. Proc Nutr Soc 62(1):67–72. doi:10.1079/PNS2002207 PubMedCrossRef

143.

Roediger WE (1980) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21(9):793–798PubMedPubMedCentralCrossRef

144.

Cummings JH (1984) Colonic absorption: the importance of short chain fatty acids in man. Scand J Gastroenterol Suppl 93:89–99PubMed

145.

Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28(10):1221–1227PubMedPubMedCentralCrossRef

146.

Cummings JH, Macfarlane GT (1991) The control and consequences of bacterial fermentation in the human colon. The Journal of applied bacteriology 70(6):443–459PubMedCrossRef

147.

Ganapathy V, Thangaraju M, Prasad PD, Martin PM, Singh N (2013) Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr Opin Pharmacol 13(6):869–874. doi:10.1016/j.coph.2013.08.006 PubMedCrossRef

148.

Frankel WL, Zhang W, Singh A, Klurfeld DM, Don S, Sakata T, Modlin I, Rombeau JL (1994) Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon. Gastroenterology 106(2):375–380PubMedCrossRef

149.

Wolever TM, Brighenti F, Royall D, Jenkins AL, Jenkins DJ (1989) Effect of rectal infusion of short chain fatty acids in human subjects. Am J Gastroenterol 84(9):1027–1033PubMed

150.

Canfora EE, Jocken JW, Blaak EE (2015) Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11(10):577–591. doi:10.1038/nrendo.2015.128 PubMedCrossRef

151.

De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Backhed F, Mithieux G (2014) Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156(1–2):84–96. doi:10.1016/j.cell.2013.12.016 PubMedCrossRef

152.

Davie JR (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr 133(7 Suppl):2485S–2493SPubMed

153.

Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ (2003) The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278(13):11312–11319. doi:10.1074/jbc.M211609200 PubMedCrossRef

154.

Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, Mellinger JD, Smith SB, Digby GJ, Lambert NA, Prasad PD, Ganapathy V (2009) GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 69(7):2826–2832. doi:10.1158/0008-5472.CAN-08-4466 PubMedPubMedCentralCrossRef

155.

Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J, Parmentier M, Detheux M (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278(28):25481–25489. doi:10.1074/jbc.M301403200 PubMedCrossRef

156.

Nilsson NE, Kotarsky K, Owman C, Olde B (2003) Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 303(4):1047–1052PubMedCrossRef

157.

Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104(34):13780–13785. doi:10.1073/pnas.0706625104 PubMedPubMedCentralCrossRef

158.

Treem WR, Ahsan N, Shoup M, Hyams JS (1994) Fecal short-chain fatty acids in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 18(2):159–164PubMedCrossRef

159.

Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453(7195):620–625. doi:10.1038/nature07008 PubMedCrossRef

160.

Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 107(27):12204–12209. doi:10.1073/pnas.0909122107 PubMedPubMedCentralCrossRef

161.

Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461(7268):1282–U1119. doi:10.1038/nature08530 PubMedPubMedCentralCrossRef

162.

Sina C, Gavrilova O, Forster M, Till A, Derer S, Hildebrand F, Raabe B, Chalaris A, Scheller J, Rehmann A, Franke A, Ott S, Hasler R, Nikolaus S, Folsch UR, Rose-John S, Jiang HP, Li J, Schreiber S, Rosenstiel P (2009) G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol 183(11):7514–7522. doi:10.4049/jimmunol.0900063 PubMedCrossRef

163.

Fournier BM, Parkos CA (2012) The role of neutrophils during intestinal inflammation. Mucosal immunology 5(4):354–366. doi:10.1038/mi.2012.24 PubMedCrossRef

164.

Vinolo MA, Hatanaka E, Lambertucci RH, Newsholme P, Curi R (2009) Effects of short chain fatty acids on effector mechanisms of neutrophils. Cell Biochem Funct 27(1):48–55. doi:10.1002/cbf.1533 PubMedCrossRef

165.

Vinolo MA, Rodrigues HG, Hatanaka E, Hebeda CB, Farsky SH, Curi R (2009) Short-chain fatty acids stimulate the migration of neutrophils to inflammatory sites. Clin Sci 117(9):331–338. doi:10.1042/CS20080642 PubMedCrossRef

166.

Vinolo MA, Ferguson GJ, Kulkarni S, Damoulakis G, Anderson K, Bohlooly YM, Stephens L, Hawkins PT, Curi R (2011) SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One 6(6):e21205. doi:10.1371/journal.pone.0021205 PubMedPubMedCentralCrossRef

167.

Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M (2014) Dextran sulfate sodium (DSS) induced colitis in mice. Curr Protoc Immunol 104:Unit 15 25. doi:10.1002/0471142735.im1525s104

168.

Chang PV, Hao L, Offermanns S, Medzhitov R (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A 111(6):2247–2252. doi:10.1073/pnas.1322269111 PubMedPubMedCentralCrossRef

169.

Nastasi C, Candela M, Bonefeld CM, Geisler C, Hansen M, Krejsgaard T, Biagi E, Andersen MH, Brigidi P, Odum N, Litman T, Woetmann A (2015) The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci Rep 5:16148. doi:10.1038/srep16148 PubMedPubMedCentralCrossRef

170.

Iraporda C, Errea A, Romanin DE, Cayet D, Pereyra E, Pignataro O, Sirard JC, Garrote GL, Abraham AG, Rumbo M (2015) Lactate and short chain fatty acids produced by microbial fermentation downregulate proinflammatory responses in intestinal epithelial cells and myeloid cells. Immunobiology 220(10):1161–1169. doi:10.1016/j.imbio.2015.06.004 PubMedCrossRef

171.

Andrade-Oliveira V, Amano MT, Correa-Costa M, Castoldi A, Felizardo RJ, de Almeida DC, Bassi EJ, Moraes-Vieira PM, Hiyane MI, Rodas AC, Peron JP, Aguiar CF, Reis MA, Ribeiro WR, Valduga CJ, Curi R, Vinolo MA, Ferreira CM, Camara NO (2015) Gut bacteria products prevent AKI induced by ischemia-reperfusion. Journal of the American Society of Nephrology : JASN 26(8):1877–1888. doi:10.1681/ASN.2014030288 PubMedPubMedCentralCrossRef

172.

Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504(7480):451–455. doi:10.1038/nature12726 PubMedPubMedCentralCrossRef

173.

Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, Lee JR, Offermanns S, Ganapathy V (2014) Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40(1):128–139. doi:10.1016/j.immuni.2013.12.007 PubMedPubMedCentralCrossRef

174.

Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446–450. doi:10.1038/nature12721 PubMedCrossRef

175.

Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, Glickman JN, Garrett WS (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341(6145):569–573. doi:10.1126/science.1241165 PubMedCrossRef

176.

Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM, Li B, Turka LA, Olson EN, Greene MI, Wells AD, Hancock WW (2007) Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 13(11):1299–1307. doi:10.1038/nm1652 PubMedCrossRef

177.

de Zoeten EF, Wang L, Sai H, Dillmann WH, Hancock WW (2010) Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology 138(2):583–594. doi:10.1053/j.gastro.2009.10.037 PubMedCrossRef

178.

Wang LQ, de Zoeten EF, Greene MI, Hancock WW (2009) Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3 (+) regulatory T cells. Nat Rev Drug Discov 8(12):969–981. doi:10.1038/nrd3031 PubMedPubMedCentral

179.

Beier UH, Wang L, Han R, Akimova T, Liu Y, Hancock WW (2012) Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Science signaling 5(229):ra45. doi:10.1126/scisignal.2002873 PubMedPubMedCentralCrossRef

180.

Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J, Kim CH (2015) Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6 K pathway. Mucosal immunology 8(1):80–93. doi:10.1038/mi.2014.44 PubMedCrossRef

181.

Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Utermohlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18(7):965–977. doi:10.1038/nn.4030 PubMedCrossRef

182.

Vinolo MA, Rodrigues HG, Nachbar RT, Curi R (2011) Regulation of inflammation by short chain fatty acids. Nutrients 3(10):858–876. doi:10.3390/nu3100858 PubMedPubMedCentralCrossRef

183.

Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142(5):687–698. doi:10.1016/j.cell.2010.07.041 PubMedPubMedCentralCrossRef

184.

Talukdar S, Olefsky JM, Osborn O (2011) Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol Sci 32(9):543–550. doi:10.1016/j.tips.2011.04.004 PubMedPubMedCentralCrossRef

185.

Fujita T, Matsuoka T, Honda T, Kabashima K, Hirata T, Narumiya S (2011) A GPR40 agonist GW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation. The Journal of investigative dermatology 131(8):1660–1667. doi:10.1038/jid.2011.123 PubMedCrossRef

186.

Suzuki M, Takaishi S, Nagasaki M, Onozawa Y, Iino I, Maeda H, Komai T, Oda T (2013) Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor. J Biol Chem 288(15):10684–10691. doi:10.1074/jbc.M112.420042 PubMedPubMedCentralCrossRef

187.

Blomhoff R, Blomhoff HK (2006) Overview of retinoid metabolism and function. J Neurobiol 66(7):606–630. doi:10.1002/neu.20242 PubMedCrossRef

188.

Giguere V, Ong ES, Segui P, Evans RM (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330(6149):624–629. doi:10.1038/330624a0 PubMedCrossRef

189.

Petkovich M, Brand NJ, Krust A, Chambon P (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330(6147):444–450. doi:10.1038/330444a0 PubMedCrossRef

190.

Balmer JE, Blomhoff R (2002) Gene expression regulation by retinoic acid. J Lipid Res 43:1773–808. doi:10.1194/jlr.R100015-JLR200

191.

Beijer MR, Kraal G, den Haan JM (2014) Vitamin A and dendritic cell differentiation. Immunology 142(1):39–45PubMedPubMedCentralCrossRef

192.

Klebanoff CA, Spencer SP, Torabi-Parizi P, Grainger JR, Roychoudhuri R, Ji Y, Sukumar M, Muranski P, Scott CD, Hall JA, Ferreyra GA, Leonardi AJ, Borman ZA, Wang J, Palmer DC, Wilhelm C, Cai R, Sun J, Napoli JL, Danner RL, Gattinoni L, Belkaid Y, Restifo NP (2013) Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells. J Exp Med 210(10):1961–1976. doi:10.1084/jem.20122508 PubMedPubMedCentralCrossRef

193.

Zeng R, Bscheider M, Lahl K, Lee M, Butcher EC (2016) Generation and transcriptional programming of intestinal dendritic cells: essential role of retinoic acid. Mucosal immunology 9(1):183–193. doi:10.1038/mi.2015.50 PubMedCrossRef

194.

Haileselassie Y, Navis M, Vu N, Qazi KR, Rethi B, Sverremark-Ekstrom E (2016) Postbiotic modulation of retinoic acid imprinted mucosal-like dendritic cells by probiotic lactobacillus reuteri 17938 in vitro. Front Immunol 7:96. doi:10.3389/fimmu.2016.00096 PubMedPubMedCentralCrossRef

195.

Bakdash G, Vogelpoel LT, van Capel TM, Kapsenberg ML, de Jong EC (2015) Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells. Mucosal immunology 8(2):265–278. doi:10.1038/mi.2014.64 PubMedCrossRef

196.

Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY (2004) Retinoic acid imprints gut-homing specificity on T cells. Immunity 21(4):527–538. doi:10.1016/j.immuni.2004.08.011 PubMedCrossRef

197.

Manicassamy S, Ravindran R, Deng J, Oluoch H, Denning TL, Kasturi SP, Rosenthal KM, Evavold BD, Pulendran B (2009) Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med 15(4):401–409. doi:10.1038/nm.1925 PubMedPubMedCentralCrossRef

198.

Wang S, Villablanca EJ, De Calisto J, Gomes DC, Nguyen DD, Mizoguchi E, Kagan JC, Reinecker HC, Hacohen N, Nagler C, Xavier RJ, Rossi-Bergmann B, Chen YB, Blomhoff R, Snapper SB, Mora JR (2011) MyD88-dependent TLR1/2 signals educate dendritic cells with gut-specific imprinting properties. J Immunol 187(1):141–150. doi:10.4049/jimmunol.1003740 PubMedPubMedCentralCrossRef

199.

Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ (2007) All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204(8):1765–1774. doi:10.1084/jem.20070719 PubMedPubMedCentralCrossRef

200.

Kang SG, Lim HW, Andrisani OM, Broxmeyer HE, Kim CH (2007) Vitamin a metabolites induce gut-homing FoxP3+ regulatory T cells. J Immunol 179(6):3724–3733PubMedCrossRef

201.

Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204(8):1775–1785. doi:10.1084/jem.20070602 PubMedPubMedCentralCrossRef

202.

Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, Shevach EM, O'Shea JJ (2008) Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a stat-3/stat-5 independent signaling pathway. Blood 111(3):1013–1020. doi:10.1182/blood-2007-06-096438 PubMedPubMedCentralCrossRef

203.

Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317(5835):256–260. doi:10.1126/science.1145697 PubMedCrossRef

204.

Schambach F, Schupp M, Lazar MA, Reiner SL (2007) Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol 37(9):2396–2399. doi:10.1002/eji.200737621 PubMedCrossRef

205.

De Leenheer AP, Lambert WE, Claeys I (1982) All-trans-retinoic acid: measurement of reference values in human serum by high performance liquid chromatography. J Lipid Res 23(9):1362–1367PubMed

206.

Uematsu S, Fujimoto K, Jang MH, Yang BG, Jung YJ, Nishiyama M, Sato S, Tsujimura T, Yamamoto M, Yokota Y, Kiyono H, Miyasaka M, Ishii KJ, Akira S (2008) Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing toll-like receptor 5. Nat Immunol 9(7):769–776. doi:10.1038/ni.1622 PubMedCrossRef

207.

Cha HR, Chang SY, Chang JH, Kim JO, Yang JY, Kim CH, Kweon MN (2010) Downregulation of Th17 cells in the small intestine by disruption of gut flora in the absence of retinoic acid. J Immunol 184(12):6799–6806. doi:10.4049/jimmunol.0902944 PubMedCrossRef

208.

Wang C, Kang SG, HogenEsch H, Love PE, Kim CH (2010) Retinoic acid determines the precise tissue tropism of inflammatory Th17 cells in the intestine. J Immunol 184(10):5519–5526. doi:10.4049/jimmunol.0903942 PubMedPubMedCentralCrossRef

209.

Pino-Lagos K, Guo Y, Brown C, Alexander MP, Elgueta R, Bennett KA, De Vries V, Nowak E, Blomhoff R, Sockanathan S, Chandraratna RA, Dmitrovsky E, Noelle RJ (2011) A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunity. J Exp Med 208(9):1767–1775. doi:10.1084/jem.20102358 PubMedPubMedCentralCrossRef

210.

Hall JA, Cannons JL, Grainger JR, Dos Santos LM, Hand TW, Naik S, Wohlfert EA, Chou DB, Oldenhove G, Robinson M, Grigg ME, Kastenmayer R, Schwartzberg PL, Belkaid Y (2011) Essential role for retinoic acid in the promotion of CD4 (+) T cell effector responses via retinoic acid receptor alpha. Immunity 34(3):435–447. doi:10.1016/j.immuni.2011.03.003 PubMedPubMedCentralCrossRef

211.

Sommer A, Tarwotjo I, Hussaini G, Susanto D (1983) Increased mortality in children with mild vitamin a deficiency. Lancet 2(8350):585–588PubMedCrossRef

212.

Stephens D, Jackson PL, Gutierrez Y (1996) Subclinical vitamin a deficiency: a potentially unrecognized problem in the United States. Pediatr Nurs 22(5):377–389 456PubMed

213.

Sommer A, Tarwotjo I, Djunaedi E, West KP Jr, Loeden AA, Tilden R, Mele L (1986) Impact of vitamin a supplementation on childhood mortality. A randomised controlled community trial. Lancet 1(8491):1169–1173PubMedCrossRef

214.

Imdad A, Yakoob MY, Sudfeld C, Haider BA, Black RE, Bhutta ZA (2011) Impact of vitamin A supplementation on infant and childhood mortality. BMC public health 11(Suppl 3):S20. doi:10.1186/1471-2458-11-S3-S20 PubMedPubMedCentralCrossRef

215.

Mora JR, Iwata M, Eksteen B, Song SY, Junt T, Senman B, Otipoby KL, Yokota A, Takeuchi H, Ricciardi-Castagnoli P, Rajewsky K, Adams DH, von Andrian UH (2006) Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314(5802):1157–1160. doi:10.1126/science.1132742 PubMedCrossRef

216.

Rudraraju R, Surman SL, Jones BG, Sealy R, Woodland DL, Hurwitz JL (2012) Reduced frequencies and heightened CD103 expression among virus-induced CD8(+) T cells in the respiratory tract airways of vitamin A-deficient mice. Clinical and vaccine immunology : CVI 19(5):757–765. doi:10.1128/CVI.05576-11 PubMedPubMedCentralCrossRef

217.

Surman SL, Rudraraju R, Sealy R, Jones B, Hurwitz JL (2012) Vitamin a deficiency disrupts vaccine-induced antibody-forming cells and the balance of IgA/IgG isotypes in the upper and lower respiratory tract. Viral Immunol 25(4):341–344. doi:10.1089/vim.2012.0023 PubMedPubMedCentralCrossRef

218.

Surman SL, Jones BG, Rudraraju R, Sealy RE, Hurwitz JL (2014) Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host. Clinical and vaccine immunology : CVI 21(4):598–601. doi:10.1128/CVI.00757-13 PubMedPubMedCentralCrossRef

219.

Surman SL, Jones BG, Sealy RE, Rudraraju R, Hurwitz JL (2014) Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin a deficient mice. Vaccine 32(22):2521–2524. doi:10.1016/j.vaccine.2014.03.025 PubMedPubMedCentralCrossRef

220.

DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80(6 Suppl):1689S–1696SPubMed

221.

Omdahl JL, Morris HA, May BK (2002) Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Annu Rev Nutr 22:139–166. doi:10.1146/annurev.nutr.22.120501.150216 PubMedCrossRef

222.

Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74(2):657–661. doi:10.1172/JCI111465 PubMedPubMedCentralCrossRef

223.

Rigby WF, Stacy T, Fanger MW (1984) Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 74(4):1451–1455. doi:10.1172/JCI111557 PubMedPubMedCentralCrossRef

224.

Bhalla AK, Amento EP, Krane SM (1986) Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 98(2):311–322PubMedCrossRef

225.

Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM (1983) Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57(6):1308–1310. doi:10.1210/jcem-57-6-1308 PubMedCrossRef

226.

Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221(4616):1181–1183PubMedCrossRef

227.

Lemire JM, Archer DC (1991) 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87(3):1103–1107. doi:10.1172/JCI115072 PubMedPubMedCentralCrossRef

228.

Cantorna MT, Hayes CE, DeLuca HF (1996) 1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93(15):7861–7864PubMedPubMedCentralCrossRef

229.

Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R (1992) 1,25-dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 41(11):1491–1495PubMedCrossRef

230.

Haussler MR, Haussler CA, Bartik L, Whitfield GK, Hsieh JC, Slater S, Jurutka PW (2008) Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 66(10 Suppl 2):S98–112. doi:10.1111/j.1753-4887.2008.00093.x PubMedCrossRef

231.

Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R (2001) Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A 98(12):6800–6805. doi:10.1073/pnas.121172198 PubMedPubMedCentralCrossRef

232.

Penna G, Adorini L (2000) 1 alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164(5):2405–2411PubMedCrossRef

233.

Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V (2000) Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164(9):4443–4451PubMedCrossRef

234.

Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA (2001) 1-alpha,25-dihydroxyvitamin D3 (1,25 (OH) (2)D (3)) hampers the maturation of fully active immature dendritic cells from monocytes. European journal of endocrinology / European Federation of Endocrine Societies 145(3):351–357CrossRef

235.

Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R (2000) Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 270(3):701–708. doi:10.1006/bbrc.2000.2490 PubMedCrossRef

236.

Berer A, Stockl J, Majdic O, Wagner T, Kollars M, Lechner K, Geissler K, Oehler L (2000) 1,25-dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 28(5):575–583PubMedCrossRef

237.

Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO (2009) Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol 39(11):3147–3159. doi:10.1002/eji.200839103 PubMedCrossRef

238.

Ferreira GB, van Etten E, Verstuyf A, Waer M, Overbergh L, Gysemans C, Mathieu C (2011) 1,25-dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metab Res Rev 27(8):933–941. doi:10.1002/dmrr.1275 PubMedCrossRef

239.

Harant H, Wolff B, Lindley IJ (1998) 1Alpha,25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts. FEBS Lett 436(3):329–334PubMedCrossRef

240.

D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P (1998) Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101(1):252–262. doi:10.1172/JCI1050 PubMedPubMedCentralCrossRef

241.

Wu S, Liao AP, Xia Y, Li YC, Li JD, Sartor RB, Sun J (2010) Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol 177(2):686–697. doi:10.2353/ajpath.2010.090998 PubMedPubMedCentralCrossRef

242.

Szeto FL, Sun J, Kong J, Duan Y, Liao A, Madara JL, Li YC (2007) Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibroblasts. J Steroid Biochem Mol Biol 103(3–5):563–566. doi:10.1016/j.jsbmb.2006.12.092 PubMedCrossRef

243.

Chen Y, Zhang J, Ge X, Du J, Deb DK, Li YC (2013) Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem 288(27):19450–19458. doi:10.1074/jbc.M113.467670 PubMedPubMedCentralCrossRef

244.

Ferreira GB, Kleijwegt FS, Waelkens E, Lage K, Nikolic T, Hansen DA, Workman CT, Roep BO, Overbergh L, Mathieu C (2012) Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells. J Proteome Res 11(2):941–971. doi:10.1021/pr200724e PubMedCrossRef

245.

Ferreira GB, Vanherwegen AS, Eelen G, Gutierrez AC, Van Lommel L, Marchal K, Verlinden L, Verstuyf A, Nogueira T, Georgiadou M, Schuit F, Eizirik DL, Gysemans C, Carmeliet P, Overbergh L, Mathieu C (2015) Vitamin D3 induces tolerance in human dendritic cells by activation of intracellular metabolic pathways. Cell Rep. doi:10.1016/j.celrep.2015.01.013

246.

Malinarich F, Duan K, Hamid RA, Bijin A, Lin WX, Poidinger M, Fairhurst AM, Connolly JE (2015) High mitochondrial respiration and glycolytic capacity represent a metabolic phenotype of human tolerogenic dendritic cells. J Immunol 194(11):5174–5186. doi:10.4049/jimmunol.1303316 PubMedCrossRef

247.

Lips P (2007) Relative value of 25(OH)D and 1,25(OH)2D measurements. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 22(11):1668–1671. doi:10.1359/jbmr.070716 CrossRef

248.

Reichel H, Koeffler HP, Norman AW (1987) Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages. J Biol Chem 262(23):10931–10937PubMed

249.

Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, Reichel H (1993) 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 82(4):1300–1307PubMed

250.

Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M (2003) Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood 102(9):3314–3316. doi:10.1182/blood-2002-11-3521 PubMedCrossRef

251.

Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PA, Chakraverty R (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170(11):5382–5390PubMedCrossRef

252.

Jeffery LE, Wood AM, Qureshi OS, Hou TZ, Gardner D, Briggs Z, Kaur S, Raza K, Sansom DM (2012) Availability of 25-hydroxyvitamin D (3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol 189(11):5155–5164. doi:10.4049/jimmunol.1200786 PubMedPubMedCentralCrossRef

253.

Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, Walker LS, Lammas DA, Raza K, Sansom DM (2009) 1,25-dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 183(9):5458–5467. doi:10.4049/jimmunol.0803217 PubMedPubMedCentralCrossRef

254.

Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, Butcher EC (2007) DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8(3):285–293. doi:10.1038/ni1433 PubMedCrossRef

255.

van der Aar AM, Sibiryak DS, Bakdash G, van Capel TM, van der Kleij HP, Opstelten DJ, Teunissen MB, Kapsenberg ML, de Jong EC (2011) Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells. The Journal of allergy and clinical immunology 127(6):1532–1540 . doi:10.1016/j.jaci.2011.01.068e1537PubMedCrossRef

256.

Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87(4):1080S–1086SPubMed

257.

Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. The Lancet Neurology 9(5):520–532. doi:10.1016/S1474-4422(10)70064-8 PubMedCrossRef

258.

Ascherio A, Munger KL, White R, Kochert K, Simon KC, Polman CH, Freedman MS, Hartung HP, Miller DH, Montalban X, Edan G, Barkhof F, Pleimes D, Radu EW, Sandbrink R, Kappos L, Pohl C (2014) Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA neurology 71(3):306–314. doi:10.1001/jamaneurol.2013.5993 PubMedPubMedCentralCrossRef

259.

Sotirchos ES, Bhargava P, Eckstein C, Van Haren K, Baynes M, Ntranos A, Gocke A, Steinman L, Mowry EM, Calabresi PA (2016) Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis. Neurology 86(4):382–390. doi:10.1212/WNL.0000000000002316 PubMedPubMedCentralCrossRef

260.

Zurück zum Zitat International Multiple Sclerosis Genetics C, Wellcome Trust Case Control C, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D'Alfonso S, Blackburn H, Martinelli Boneschi F, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget-Darpoux F, Clysters K, Comi G, Cossburn M, Cournu-Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D'Hooghe MB, Dixon K, Dobosi R, Dubois B, Ellinghaus D, Elovaara I, Esposito F, Fontenille C, Foote S, Franke A, Galimberti D, Ghezzi A, Glessner J, Gomez R, Gout O, Graham C, Grant SF, Guerini FR, Hakonarson H, Hall P, Hamsten A, Hartung HP, Heard RN, Heath S, Hobart J, Hoshi M, Infante-Duarte C, Ingram G, Ingram W, Islam T, Jagodic M, Kabesch M, Kermode AG, Kilpatrick TJ, Kim C, Klopp N, Koivisto K, Larsson M, Lathrop M, Lechner-Scott JS, Leone MA, Leppa V, Liljedahl U, Bomfim IL, Lincoln RR, Link J, Liu J, Lorentzen AR, Lupoli S, Macciardi F, Mack T, Marriott M, Martinelli V, Mason D, McCauley JL, Mentch F, Mero IL, Mihalova T, Montalban X, Mottershead J, Myhr KM, Naldi P, Ollier W, Page A, Palotie A, Pelletier J, Piccio L, Pickersgill T, Piehl F, Pobywajlo S, Quach HL, Ramsay PP, Reunanen M, Reynolds R, Rioux JD, Rodegher M, Roesner S, Rubio JP, Ruckert IM, Salvetti M, Salvi E, Santaniello A, Schaefer CA, Schreiber S, Schulze C, Scott RJ, Sellebjerg F, Selmaj KW, Sexton D, Shen L, Simms-Acuna B, Skidmore S, Sleiman PM, Smestad C, Sorensen PS, Sondergaard HB, Stankovich J, Strange RC, Sulonen AM, Sundqvist E, Syvanen AC, Taddeo F, Taylor B, Blackwell JM, Tienari P, Bramon E, Tourbah A, Brown MA, Tronczynska E, Casas JP, Tubridy N, Corvin A, Vickery J, Jankowski J, Villoslada P, Markus HS, Wang K, Mathew CG, Wason J, Palmer CN, Wichmann HE, Plomin R, Willoughby E, Rautanen A, Winkelmann J, Wittig M, Trembath RC, Yaouanq J, Viswanathan AC, Zhang H, Wood NW, Zuvich R, Deloukas P, Langford C, Duncanson A, Oksenberg JR, Pericak-Vance MA, Haines JL, Olsson T, Hillert J, Ivinson AJ, De Jager PL, Peltonen L, Stewart GJ, Hafler DA, Hauser SL, McVean G, Donnelly P, Compston A (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359):214–219. doi:10.1038/nature10251 CrossRef International Multiple Sclerosis Genetics C, Wellcome Trust Case Control C, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D'Alfonso S, Blackburn H, Martinelli Boneschi F, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget-Darpoux F, Clysters K, Comi G, Cossburn M, Cournu-Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D'Hooghe MB, Dixon K, Dobosi R, Dubois B, Ellinghaus D, Elovaara I, Esposito F, Fontenille C, Foote S, Franke A, Galimberti D, Ghezzi A, Glessner J, Gomez R, Gout O, Graham C, Grant SF, Guerini FR, Hakonarson H, Hall P, Hamsten A, Hartung HP, Heard RN, Heath S, Hobart J, Hoshi M, Infante-Duarte C, Ingram G, Ingram W, Islam T, Jagodic M, Kabesch M, Kermode AG, Kilpatrick TJ, Kim C, Klopp N, Koivisto K, Larsson M, Lathrop M, Lechner-Scott JS, Leone MA, Leppa V, Liljedahl U, Bomfim IL, Lincoln RR, Link J, Liu J, Lorentzen AR, Lupoli S, Macciardi F, Mack T, Marriott M, Martinelli V, Mason D, McCauley JL, Mentch F, Mero IL, Mihalova T, Montalban X, Mottershead J, Myhr KM, Naldi P, Ollier W, Page A, Palotie A, Pelletier J, Piccio L, Pickersgill T, Piehl F, Pobywajlo S, Quach HL, Ramsay PP, Reunanen M, Reynolds R, Rioux JD, Rodegher M, Roesner S, Rubio JP, Ruckert IM, Salvetti M, Salvi E, Santaniello A, Schaefer CA, Schreiber S, Schulze C, Scott RJ, Sellebjerg F, Selmaj KW, Sexton D, Shen L, Simms-Acuna B, Skidmore S, Sleiman PM, Smestad C, Sorensen PS, Sondergaard HB, Stankovich J, Strange RC, Sulonen AM, Sundqvist E, Syvanen AC, Taddeo F, Taylor B, Blackwell JM, Tienari P, Bramon E, Tourbah A, Brown MA, Tronczynska E, Casas JP, Tubridy N, Corvin A, Vickery J, Jankowski J, Villoslada P, Markus HS, Wang K, Mathew CG, Wason J, Palmer CN, Wichmann HE, Plomin R, Willoughby E, Rautanen A, Winkelmann J, Wittig M, Trembath RC, Yaouanq J, Viswanathan AC, Zhang H, Wood NW, Zuvich R, Deloukas P, Langford C, Duncanson A, Oksenberg JR, Pericak-Vance MA, Haines JL, Olsson T, Hillert J, Ivinson AJ, De Jager PL, Peltonen L, Stewart GJ, Hafler DA, Hauser SL, McVean G, Donnelly P, Compston A (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359):214–219. doi:10.1038/nature10251 CrossRef

261.

Australia, New Zealand Multiple Sclerosis Genetics C (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41(7):824–828. doi:10.1038/ng.396 CrossRef

262.

Ramagopalan SV, Dyment DA, Cader MZ, Morrison KM, Disanto G, Morahan JM, Berlanga-Taylor AJ, Handel A, De Luca GC, Sadovnick AD, Lepage P, Montpetit A, Ebers GC (2011) Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann Neurol 70(6):881–886. doi:10.1002/ana.22678 PubMedCrossRef

263.

Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton SM, Watson CT, Morahan JM, Giovannoni G, Ponting CP, Ebers GC, Knight JC (2010) A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 20(10):1352–1360. doi:10.1101/gr.107920.110 PubMedPubMedCentralCrossRef

264.

Tizaoui K, Kaabachi W, Hamzaoui A, Hamzaoui K (2015) Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies. Cellular & molecular immunology 12(2):243–252. doi:10.1038/cmi.2014.47 CrossRef

265.

Blanck S, Aberra F (2013) Vitamin d deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci 58(6):1698–1702. doi:10.1007/s10620-012-2531-7

266.

Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, Issa M (2011) Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr 35(3):308–316. doi:10.1177/0148607110381267

267.

Froicu M, Cantorna MT (2007) Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 8:5. doi:10.1186/1471-2172-8-5

268.

Ooi JH, Li Y, Rogers CJ, Cantorna MT (2013) Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr 143(10):1679–1686. doi:10.3945/jn.113.180794

269.

Froicu M, Zhu Z, Cantorna MT (2006) Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 117:310–318. doi:10.1111/j.1365-2567.2005.02290.x

270.

Quintana FJ, Sherr DH (2013) Aryl hydrocarbon receptor control of adaptive immunity. Pharmacol Rev 65(4):1148–1161. doi:10.1124/pr.113.007823 PubMedPubMedCentralCrossRef

271.

Cyster JG, Dang EV, Reboldi A, Yi T (2014) 25-hydroxycholesterols in innate and adaptive immunity. Nat Rev Immunol 14(11):731–743. doi:10.1038/nri3755 PubMedCrossRef

272.

Basil MC, Levy BD (2016) Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 16(1):51–67. doi:10.1038/nri.2015.4 PubMedCrossRef

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Metabolites: deciphering the molecular language between DCs and their environment

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Erratum to: Novel immunoregulatory role of perforin-positive dendritic cells

The role of NLRP3 and AIM2 in inflammasome activation during Brucella abortus infection

The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues

Dendritic cells as gatekeepers of tolerance

The development of dendritic cell vaccine-based immunotherapies for glioblastoma